{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:13:16Z","timestamp":1791342796315,"version":"4.3.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council Confidence"},{"name":"Southeast Scotland Research Ethics Committee"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jcv.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T18:31:25Z","timestamp":1535740285000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples"],"prefix":"10.1016","volume":"108","author":[{"given":"Andrew","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Doorbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Deeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Cuschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7140-8279","authenticated-orcid":false,"given":"Sheila V.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2018.08.011_bib0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"Stanley","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2018.08.011_bib0010","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3390\/v7072802","article-title":"Human papillomaviruses; epithelial tropisms, and the development of neoplasia","volume":"7","author":"Egawa","year":"2015","journal-title":"Viruses."},{"key":"10.1016\/j.jcv.2018.08.011_bib0015","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1042\/CS20160786","article-title":"The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review","volume":"131","author":"Graham","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jcv.2018.08.011_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jviromet.2004.11.005","article-title":"Assessment of human papillomvirus mRNA detection over time in cervical specimens collected in liquid based cytology medium","volume":"124","author":"Cuschieri","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2018.08.011_bib0025","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jcv.2004.12.006","article-title":"The papillomavirus life cycle","volume":"32S","author":"Doorbar","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.2192","article-title":"Integration of high-risk human papillomvirus: a key event in crvical carcinogenesis?","volume":"212","author":"Pett","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0040","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcv.2018.08.011_bib0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/AJCP3TPHV4TRIZEK","article-title":"p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement","volume":"142","author":"Reuschenbach","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0050","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1128\/JVI.77.19.10186-10201.2003","article-title":"Organisation of the human papillomavirus productive cycle during neoplastic progression provides a basis for the selection of diagnostic markers","volume":"77","author":"Middleton","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/cncr.23951","article-title":"Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material","volume":"114","author":"Halloush","year":"2008","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/modpathol.2015.52","article-title":"Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM","volume":"28","author":"Griffin","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049974","article-title":"E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease","volume":"7","author":"Griffin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcv.2018.08.011_bib0070","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/PAS.0000000000000498","article-title":"Investigating diagnostic problems of CIN1 and 2 associated with high-risk HPV by combining the novel molecular biomarker panHPV E4 with p16(ink4a)","volume":"39","author":"van Baars","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0075","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.ejca.2009.07.024","article-title":"What\u2019s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination","volume":"45","author":"Lynge","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jcv.2018.08.011_bib0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.jcv.2018.08.011_bib0085","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jcv.2015.10.008","article-title":"HPV testing in the context of post-treatment follow up (test of cure)","volume":"76","author":"Cuschieri","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","article-title":"Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial","volume":"14","author":"Carozzi","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejogrb.2017.01.009","article-title":"Diagnostic performance of dual-staining cytology for cervical cancer screening: a systematic literature review","volume":"210","author":"Tjalma","year":"2017","journal-title":"Eur. J. Obs. Gynecol. Rep. Biol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1471-0528.13076","article-title":"A systematic review of p16\/Ki-67 immuno-testing for triage of low grade cervical cytology","volume":"122","author":"Kisser","year":"2015","journal-title":"BJOG: Int. J. Obs. Gynaecol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1568009054629654","article-title":"The MCM complex: its role in DNA replication and implications for cancer Therapy","volume":"5","author":"Lei","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jcv.2018.08.011_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","article-title":"The papillomavirus E7 proteins","volume":"445","author":"Roman","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2018.08.011_bib0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2013.04.026","article-title":"Papillomavirus E6 oncoproteins","volume":"445","author":"Vande Pol","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2018.08.011_bib0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/fmb.11.87","article-title":"Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts","volume":"6","author":"Sahasrabuddhe","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jcv.2018.08.011_bib0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7150\/ijms.6526","article-title":"Immunostaining of p16INK4\/Ki-67 and L1 capsid protein on liquid based cytology specimens obtained from ASC-H and LSIL-H cases","volume":"10","author":"Byun","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jcv.2018.08.011_bib0130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ijc.31368","article-title":"Clinical evaluation of human papillomavirus 16\/18 oncoprotein test for cervical cancer screening and HPV positive women triage","volume":"143","author":"Yu","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2018.08.011_bib0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/modpathol.2012.233","article-title":"HPV L1 detection discriminates cervical precancer from transient HPV infection: a prospective international multicenter study","volume":"26","author":"Mehlhorn","year":"2013","journal-title":"Mod. Pathol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218302208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218302208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T02:13:41Z","timestamp":1554257621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653218302208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":27,"alternative-id":["S1386653218302208"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2018.08.011","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}